5i Research Weekly Rockets and Duds
Welcome to week eight of 5i Research's market ROCKETS AND DUDS
Akero Therapeutics Inc. AKRO 
Dry January may be over, but people still get cirrhosis of the liver. Akero soared 107% last week as its experimental drug actually reversed cirrhosis in a study of patients with the disease. After 96 weeks of treatment, liver damage retreated in 39% of the patients who received 50 mg doses of the company's drug. The company used the stellar results and stock double to raise $350 million with a new stock sale, with the proceeds going towards further research.
Dry January may be over, but people still get cirrhosis of the liver. Akero soared 107% last week as its experimental drug actually reversed cirrhosis in a study of patients with the disease. After 96 weeks of treatment, liver damage retreated in 39% of the patients who received 50 mg doses of the company's drug. The company used the stellar results and stock double to raise $350 million with a new stock sale, with the proceeds going towards further research. 
SS Innovations International Inc. SSII There was actually no corporate news last week from SSII, but the week prior saw some press releases, and it looks like investors had a delayed reaction to the news, driving the stock up 31% in the last week of the month. ROBOT SURGEONS!! Now, there's a headline that will get people's attention. SSII announced that its robot-assisted surgery technique completed the 'world's first robotic beating heart totally endoscopic coronary artery bypass telesurgery with a latency of only 40 milliseconds'. Tightly held and based in Florida (where there are lots of seniors needing surgery!), the company's shares are now up 131% over the past year.
There was actually no corporate news last week from SSII, but the week prior saw some press releases, and it looks like investors had a delayed reaction to the news, driving the stock up 31% in the last week of the month. ROBOT SURGEONS!! Now, there's a headline that will get people's attention. SSII announced that its robot-assisted surgery technique completed the 'world's first robotic beating heart totally endoscopic coronary artery bypass telesurgery with a latency of only 40 milliseconds'. Tightly held and based in Florida (where there are lots of seniors needing surgery!), the company's shares are now up 131% over the past year. 
Jingbo Technology Inc. SVMB OK, class. Pay attention here. There is a lesson to be learned. In our weekly Rockets and Duds feature, we limit companies discussed to those with a market capitalization of more than $1 billion. Jingbo Technology qualifies in that regard. Despite its rocket status with its 167% gain last week, please do not go and rush out to buy this one. The stock, now $2.75, is DOWN 97.5% in the past year alone, and down 99.6% since June 2023. It may have been a rocket last week, but it looks like a permanent dud with those types of returns. The company makes smart parking applications software, and is based in China. We feel sorry for those who 'parked' their money in this one.
OK, class. Pay attention here. There is a lesson to be learned. In our weekly Rockets and Duds feature, we limit companies discussed to those with a market capitalization of more than $1 billion. Jingbo Technology qualifies in that regard. Despite its rocket status with its 167% gain last week, please do not go and rush out to buy this one. The stock, now $2.75, is DOWN 97.5% in the past year alone, and down 99.6% since June 2023. It may have been a rocket last week, but it looks like a permanent dud with those types of returns. The company makes smart parking applications software, and is based in China. We feel sorry for those who 'parked' their money in this one. 
Globalstar Inc. GSAT 
Have you ever wanted to call your friend at work, you know, the guy who works on the international space station? Well just use Globalstar, an international telecom infrastructure provider, supplying mobile satellite services and wholesale capacity services via satellites. No, wait, just use your iPhone instead! Globalstar shares fell 27% last week as news surfaced that Apple, T Mobile and SpaceX were working together to add support for the Starlink network in the latest iPhone update.
Have you ever wanted to call your friend at work, you know, the guy who works on the international space station? Well just use Globalstar, an international telecom infrastructure provider, supplying mobile satellite services and wholesale capacity services via satellites. No, wait, just use your iPhone instead! Globalstar shares fell 27% last week as news surfaced that Apple, T Mobile and SpaceX were working together to add support for the Starlink network in the latest iPhone update. 
Celestica CLS we have a loser! Oops, no wait, we have a winner!! We were quite sure Celestica, a maker of electronic components often used in data centres, was going to be on our 'DUDS' list after its giant 28% decline in last Monday's trading session. DeepSeek threatened to change the trajectory of AI spending patterns, and Celistica got caught in the cross-fires. But Celestica had other plans: it didn't want to be in the 'DUDS' section, it wanted to be a 'ROCKET'. So it reported solid earnings, upped its guidance, and more or less said everything in its business was 'peachy keen'. The result? A 43% 4-day surge in the stock and a gain of 3% for the week. Congratulations, Celestica (4-day) rocket!
we have a loser! Oops, no wait, we have a winner!! We were quite sure Celestica, a maker of electronic components often used in data centres, was going to be on our 'DUDS' list after its giant 28% decline in last Monday's trading session. DeepSeek threatened to change the trajectory of AI spending patterns, and Celistica got caught in the cross-fires. But Celestica had other plans: it didn't want to be in the 'DUDS' section, it wanted to be a 'ROCKET'. So it reported solid earnings, upped its guidance, and more or less said everything in its business was 'peachy keen'. The result? A 43% 4-day surge in the stock and a gain of 3% for the week. Congratulations, Celestica (4-day) rocket!
Unlock the Power of Informed Investing with 5i Research!
DIY investing doesn't have to mean going it alone. At 5i Research, we're your trusted partner in navigating the stock market. Our platform offers comprehensive stock and market research, empowering you to make smart investment decisions.
- Investor Q&A: Have burning questions? Get answers from our team of experts and fellow investors in our dedicated Q&A section.
- Research Reports: With over 60 meticulously researched Canadian stocks, our reports offer in-depth analysis, giving you the confidence to invest wisely.
- Model Portfolios, Alerts, Forums, Portfolio Tracking, and Much More...
Analysts of 5i Research responsible for this report do not have a financial or other interest in securities mentioned. The i2i Fund does not have a financial or other interest in securities mentioned.
Comments
Login to post a comment.